Product Information
FT SLEEP AID 25 MG TABLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1158 per EA under NDC 70677112901. Its NADAC has been published 156 times since Oct 11, 2023.
FDA first approved this application on Aug 27, 2004.
Strength
25 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677112901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYLAMINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA040564FDA Approved
8/27/2004
On Market Since
5/3/2023
Pharmacological Classes
Price Statistics
The NADAC for FT SLEEP AID 25 MG TABLET has been published 156 times since Oct 11, 2023, and over the history we have for it it has declined 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1158 per EA |
|---|---|
| All-time high | $0.1358 (Dec 13, 2023) |
| All-time low | $0.1042 (Aug 21, 2024) |
| 52-week high | $0.1245 |
| 52-week low | $0.1158 |
| Median price | $0.1204 |
| Average price | $0.1186 |
| Largest weekly change | +18.2% (Sep 18, 2024) |
| Weeks tracked | 156 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxylamine succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT SLEEP AID 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FT SLEEP AID 25 MG TABLET, manufactured by Strategic Sourcing Services LLC, is $0.1158 per EA (NDC 70677112901), effective Sep 30, 2026.
How has the price of FT SLEEP AID 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for FT SLEEP AID 25 MG TABLET has declined 3.4%. It has been tracked across 156 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for FT SLEEP AID 25 MG TABLET?
Since Oct 11, 2023, the NADAC for FT SLEEP AID 25 MG TABLET has ranged from a low of $0.1042 (Aug 21, 2024) to a high of $0.1358 (Dec 13, 2023), with a median of $0.1204 per EA.
Are there cheaper alternatives to FT SLEEP AID 25 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SLEEP AID 25 MG TABLET, is $0.1120 per EA — about 3% below FT SLEEP AID 25 MG TABLET.
Who manufactures FT SLEEP AID 25 MG TABLET?
FT SLEEP AID 25 MG TABLET (NDC 70677112901) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.